Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users
• We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Delker, Erin [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Statistical analysis to identify biomarkers for safety - Clark, Matthew ELSEVIER, 2018, an international journal on biomedical and psychosocial approaches, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:161 ; year:2016 ; day:1 ; month:04 ; pages:29-35 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.drugalcdep.2016.01.007 |
|---|
| Katalog-ID: |
ELV019395426 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV019395426 | ||
| 003 | DE-627 | ||
| 005 | 20230623150915.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.drugalcdep.2016.01.007 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016012000009.pica |
| 035 | |a (DE-627)ELV019395426 | ||
| 035 | |a (ELSEVIER)S0376-8716(16)00032-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.39 |2 bkl | ||
| 100 | 1 | |a Delker, Erin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users |
| 264 | 1 | |c 2016 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures. | ||
| 650 | 7 | |a Substance use |2 Elsevier | |
| 650 | 7 | |a Timeline Follow-Back (TLFB) |2 Elsevier | |
| 650 | 7 | |a HIV |2 Elsevier | |
| 650 | 7 | |a Audio Computer-Assisted Self Interview (A-CASI) |2 Elsevier | |
| 650 | 7 | |a Assessment |2 Elsevier | |
| 700 | 1 | |a Aharonovich, Efrat |4 oth | |
| 700 | 1 | |a Hasin, Deborah |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Clark, Matthew ELSEVIER |t Statistical analysis to identify biomarkers for safety |d 2018 |d an international journal on biomedical and psychosocial approaches |g Amsterdam [u.a.] |w (DE-627)ELV000553670 |
| 773 | 1 | 8 | |g volume:161 |g year:2016 |g day:1 |g month:04 |g pages:29-35 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.drugalcdep.2016.01.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.38 |j Pharmakologie |q VZ |
| 936 | b | k | |a 44.39 |j Toxikologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 161 |j 2016 |b 1 |c 0401 |h 29-35 |g 7 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
e d ed |
|---|---|
| matchkey_str |
delkererinaharonovichefrathasindeborah:2016----:neveeamnseetfvslamnseecmueieaairgsfeunyusinao |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.38 44.39 |
| publishDate |
2016 |
| allfields |
10.1016/j.drugalcdep.2016.01.007 doi GBVA2016012000009.pica (DE-627)ELV019395426 (ELSEVIER)S0376-8716(16)00032-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Delker, Erin verfasserin aut Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures. Substance use Elsevier Timeline Follow-Back (TLFB) Elsevier HIV Elsevier Audio Computer-Assisted Self Interview (A-CASI) Elsevier Assessment Elsevier Aharonovich, Efrat oth Hasin, Deborah oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:161 year:2016 day:1 month:04 pages:29-35 extent:7 https://doi.org/10.1016/j.drugalcdep.2016.01.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 161 2016 1 0401 29-35 7 045F 610 |
| spelling |
10.1016/j.drugalcdep.2016.01.007 doi GBVA2016012000009.pica (DE-627)ELV019395426 (ELSEVIER)S0376-8716(16)00032-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Delker, Erin verfasserin aut Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures. Substance use Elsevier Timeline Follow-Back (TLFB) Elsevier HIV Elsevier Audio Computer-Assisted Self Interview (A-CASI) Elsevier Assessment Elsevier Aharonovich, Efrat oth Hasin, Deborah oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:161 year:2016 day:1 month:04 pages:29-35 extent:7 https://doi.org/10.1016/j.drugalcdep.2016.01.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 161 2016 1 0401 29-35 7 045F 610 |
| allfields_unstemmed |
10.1016/j.drugalcdep.2016.01.007 doi GBVA2016012000009.pica (DE-627)ELV019395426 (ELSEVIER)S0376-8716(16)00032-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Delker, Erin verfasserin aut Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures. Substance use Elsevier Timeline Follow-Back (TLFB) Elsevier HIV Elsevier Audio Computer-Assisted Self Interview (A-CASI) Elsevier Assessment Elsevier Aharonovich, Efrat oth Hasin, Deborah oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:161 year:2016 day:1 month:04 pages:29-35 extent:7 https://doi.org/10.1016/j.drugalcdep.2016.01.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 161 2016 1 0401 29-35 7 045F 610 |
| allfieldsGer |
10.1016/j.drugalcdep.2016.01.007 doi GBVA2016012000009.pica (DE-627)ELV019395426 (ELSEVIER)S0376-8716(16)00032-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Delker, Erin verfasserin aut Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures. Substance use Elsevier Timeline Follow-Back (TLFB) Elsevier HIV Elsevier Audio Computer-Assisted Self Interview (A-CASI) Elsevier Assessment Elsevier Aharonovich, Efrat oth Hasin, Deborah oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:161 year:2016 day:1 month:04 pages:29-35 extent:7 https://doi.org/10.1016/j.drugalcdep.2016.01.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 161 2016 1 0401 29-35 7 045F 610 |
| allfieldsSound |
10.1016/j.drugalcdep.2016.01.007 doi GBVA2016012000009.pica (DE-627)ELV019395426 (ELSEVIER)S0376-8716(16)00032-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Delker, Erin verfasserin aut Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures. Substance use Elsevier Timeline Follow-Back (TLFB) Elsevier HIV Elsevier Audio Computer-Assisted Self Interview (A-CASI) Elsevier Assessment Elsevier Aharonovich, Efrat oth Hasin, Deborah oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:161 year:2016 day:1 month:04 pages:29-35 extent:7 https://doi.org/10.1016/j.drugalcdep.2016.01.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 161 2016 1 0401 29-35 7 045F 610 |
| language |
English |
| source |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:161 year:2016 day:1 month:04 pages:29-35 extent:7 |
| sourceStr |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:161 year:2016 day:1 month:04 pages:29-35 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Pharmakologie Toxikologie |
| institution |
findex.gbv.de |
| topic_facet |
Substance use Timeline Follow-Back (TLFB) HIV Audio Computer-Assisted Self Interview (A-CASI) Assessment |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Statistical analysis to identify biomarkers for safety |
| authorswithroles_txt_mv |
Delker, Erin @@aut@@ Aharonovich, Efrat @@oth@@ Hasin, Deborah @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000553670 |
| dewey-sort |
3610 |
| id |
ELV019395426 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019395426</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623150915.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2016.01.007</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016012000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019395426</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(16)00032-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Delker, Erin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance use</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Timeline Follow-Back (TLFB)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Audio Computer-Assisted Self Interview (A-CASI)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Assessment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aharonovich, Efrat</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hasin, Deborah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:161</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:1</subfield><subfield code="g">month:04</subfield><subfield code="g">pages:29-35</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2016.01.007</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">161</subfield><subfield code="j">2016</subfield><subfield code="b">1</subfield><subfield code="c">0401</subfield><subfield code="h">29-35</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Delker, Erin |
| spellingShingle |
Delker, Erin ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use Elsevier Timeline Follow-Back (TLFB) Elsevier HIV Elsevier Audio Computer-Assisted Self Interview (A-CASI) Elsevier Assessment Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users |
| authorStr |
Delker, Erin |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000553670 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users Substance use Elsevier Timeline Follow-Back (TLFB) Elsevier HIV Elsevier Audio Computer-Assisted Self Interview (A-CASI) Elsevier Assessment Elsevier |
| topic |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use Elsevier Timeline Follow-Back (TLFB) Elsevier HIV Elsevier Audio Computer-Assisted Self Interview (A-CASI) Elsevier Assessment |
| topic_unstemmed |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use Elsevier Timeline Follow-Back (TLFB) Elsevier HIV Elsevier Audio Computer-Assisted Self Interview (A-CASI) Elsevier Assessment |
| topic_browse |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Substance use Elsevier Timeline Follow-Back (TLFB) Elsevier HIV Elsevier Audio Computer-Assisted Self Interview (A-CASI) Elsevier Assessment |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
e a ea d h dh |
| hierarchy_parent_title |
Statistical analysis to identify biomarkers for safety |
| hierarchy_parent_id |
ELV000553670 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Statistical analysis to identify biomarkers for safety |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000553670 |
| title |
Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users |
| ctrlnum |
(DE-627)ELV019395426 (ELSEVIER)S0376-8716(16)00032-6 |
| title_full |
Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users |
| author_sort |
Delker, Erin |
| journal |
Statistical analysis to identify biomarkers for safety |
| journalStr |
Statistical analysis to identify biomarkers for safety |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
29 |
| author_browse |
Delker, Erin |
| container_volume |
161 |
| physical |
7 |
| class |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Delker, Erin |
| doi_str_mv |
10.1016/j.drugalcdep.2016.01.007 |
| dewey-full |
610 |
| title_sort |
interviewer-administered tlfb vs. self-administered computerized (a-casi) drug use frequency questions: a comparison in hiv-infected drug users |
| title_auth |
Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users |
| abstract |
• We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures. |
| abstractGer |
• We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures. |
| abstract_unstemmed |
• We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
| title_short |
Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users |
| url |
https://doi.org/10.1016/j.drugalcdep.2016.01.007 |
| remote_bool |
true |
| author2 |
Aharonovich, Efrat Hasin, Deborah |
| author2Str |
Aharonovich, Efrat Hasin, Deborah |
| ppnlink |
ELV000553670 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.drugalcdep.2016.01.007 |
| up_date |
2024-07-06T21:20:29.202Z |
| _version_ |
1803866162282364928 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019395426</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623150915.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2016.01.007</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016012000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019395426</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(16)00032-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Delker, Erin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Interviewer-administered TLFB vs. self-administered computerized (A-CASI) drug use frequency questions: a comparison in HIV-infected drug users</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• We evaluated agreement between Timeline Follow-Back (TLFB) and Audio Computer-Assisted Self Interview (A-CASI) among HIV positive drug users. • Patients reported more days used drugs with the A-CASI, relative to the TLFB. • Agreement between the TLFB and A-CASI on days used drug was excellent (ICC=0.80). • Ethnicity, gender and age predicted discrepant reporting between the measures.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance use</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Timeline Follow-Back (TLFB)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Audio Computer-Assisted Self Interview (A-CASI)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Assessment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aharonovich, Efrat</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hasin, Deborah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:161</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:1</subfield><subfield code="g">month:04</subfield><subfield code="g">pages:29-35</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2016.01.007</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">161</subfield><subfield code="j">2016</subfield><subfield code="b">1</subfield><subfield code="c">0401</subfield><subfield code="h">29-35</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400406 |